BlackRock Advisors’s GSK GSK Stock Holding History

BlackRock Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-609,680	Closed	-$33M	–	3725
2016 Q2	$33M	Buy	609,680 +56,320	+10%	+$2.97M	0.03%	394
2016 Q1	$28M	Buy	553,360 +277,214	+100%	+$13.8M	0.03%	450
2015 Q4	$13.9M	Buy	276,146 +264,960	+2,369%	+$13.5M	0.01%	671
2015 Q3	$538K	Hold	11,186	–	–	﹤0.01%	2152
2015 Q2	$582K	Hold	11,186	–	–	﹤0.01%	2067
2015 Q1	$645K	Hold	11,186	–	–	﹤0.01%	1891
2014 Q4	$598K	Sell	11,186 -92	-0.8%	-$5.15K	﹤0.01%	1865
2014 Q3	$648K	Hold	11,278	–	–	﹤0.01%	1760
2014 Q2	$754K	Sell	11,278 -10,090	-47%	-$683K	﹤0.01%	1700
2014 Q1	$1.43M	Hold	21,368	–	–	﹤0.01%	1317
2013 Q4	$1.43M	Sell	21,368 -140,844	-87%	-$9.13M	﹤0.01%	1306
2013 Q3	$10.2M	Sell	162,212 -24	-0%	-$1.54K	0.01%	784
2013 Q2	$10.1M	Buy	+162,236	New	+$10.3M	0.01%	777

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock Advisors's GSK Position: Q3 2016 in Review

BlackRock Advisors sold out of GSK (GSK) in Q3 2016, closing a stake of 609,680 shares — an estimated $33M sold.

BlackRock Advisors first reported a position in GSK in Q2 2013 and held it in 13 quarters. The position peaked at $33M in Q2 2016. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

BlackRock Advisors reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
BlackRock Advisors sold 609,680 GSK shares in Q3 2016, an estimated $33M.
BlackRock Advisors first reported a position in GSK in Q2 2013 and held it in 13 quarters.
BlackRock Advisors's GSK position peaked at $33M in Q2 2016.
740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on BlackRock Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.